Janssen Pharmaceutica

                   

Akela Pharma reports results for the third quarter of fiscal 2008

pharmiweb.co.uk
14-Nov-2008 1,132 related
        

Friday November 14, 6:30 am ET www.akelapharma.com Toronto Stock Exchange Symbol: AKL MONTREAL, Nov. 14 /CNW Telbec/ - News ), a drug development company focused on developing therapies for the inhalation and pain markets,...

add comment
                   

Tekmira Pharmaceuticals Reports $6.0 Million Loss in Third Quarter 2008

pharmiweb.co.uk
14-Nov-2008 6 related
        

Thursday, November 13, 2008 Website | News Archive Vancouver, BC, November 13, 2008--(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today its operating results for the third quarter of 2008. Our partner...

add comment
                   

J&J PRD and Pfizer Wild About WuXi

pharmiweb.co.uk
13-Nov-2008 1 related
        

PharmaManufacturing.com WuXi PharmaTech has become the most trusted contract R&D partner in China. At a recent conference session on outsourcing clinical drug trials, an audience member stood up and questioned his U.S.-based...

add comment
genengnews.com: Genetic Engineering genengnews.com

Cell Signaling Technology(R) Announces Renewal of PhosphoScan(R) Proteomics Research Project for...

genengnews.com
11-Nov-2008 2 related
        

News source: Business Wire Cell Signaling Technology, Inc. (CST) announced today the renewal of a research agreement with Ortho-Biotech Oncology Research & Development (ORD), a Division of Janssen Pharmaceutica, N.V., under...

add comment

VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report (EDGAR Online)

yahoo.com
06-Nov-2008
        

| Request a Trial to NEW EDGAR Online Pro Form 10-Q for VERTEX PHARMACEUTICALS INC / MA Item 2. Telaprevir, our lead drug candidate, is an oral hepatitis C protease inhibitor and one of the most advanced of a new class of...

add comment

Akela Pharma achieves second milestone in Phase III cancer pain study

pharmiweb.co.uk
01-Nov-2008 4 related
        

Akela Pharma, a drug development company focused on developing therapies for the inhalation and pain markets, has achieved the second of a series of three Fentanyl Taifun Phase III study related milestones to be paid by Janssen...

add comment
                   

J&J units must pay $13 million over pain-patch death, jury says

pharmiweb.co.uk
29-Oct-2008 1 related
        

By Jef Feeley Oct. 29 (Bloomberg) -- Janssen Pharmaceutica Products and Alza, the subsidiaries, were responsible for Susan Hodgemire's death, jurors ruled in state court in Sanford, Florida. ``We believe justice was done...

add comment
                   

J&J's Prevention Cure

pharmiweb.co.uk
28-Oct-2008
        

Johnson & Johnson earns billions selling high-tech drugs, medical devices, diagnostic tests to people who are already sick. The health care giant yesterday acquired HealthMedia, a small Michigan company that develops...

add comment
                   

J&J's Prevention Cure

forbes.com
28-Oct-2008
        

Johnson & Johnson earns billions selling high-tech drugs, medical devices, diagnostic tests to people who are already sick. The health care giant yesterday acquired HealthMedia, a small Michigan company that develops...

add comment
                   

J&J's Prevention Cure (at Forbes.com)

yahoo.com
28-Oct-2008
        

Johnson & Johnson earns billions selling high-tech drugs, medical devices, diagnostic tests to people who are already sick. The health care giant yesterday acquired HealthMedia, a small Michigan company that develops...

add comment
1 2 next